Physician profile
Stephanie E Terrell
NPI 1457033052
$1,167.80
in general payments reported to CMS, 2019-2025
17 companies · $465 in 2025
The $465 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $112 · 2024: $591 · 2025: $465.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,168.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,167.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $434.16 | 2023-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $105.21 | 2023-2024 | Xifaxan, Trulance |
| Axonics, INC. | $100.53 | 2024 | Axonics |
| Ardelyx, INC. | $100.42 | 2023-2025 | Ibsrela |
| Ironwood Pharmaceuticals, INC | $67.14 | 2024-2025 | |
| Regeneron Healthcare Solutions, INC. | $54.08 | 2024 | Dupixent |
| Ethicon US, LLC | $48.05 | 2025 | Stratafix, Surgicel Nu-Knit, Evarrest |
| Madrigal Pharmaceuticals | $44.26 | 2024-2025 | Resmetirom, Rezdiffra |
| Ipsen Biopharmaceuticals, INC | $38.98 | 2025 | Iqirvo |
| Takeda Pharmaceuticals U.S.A., INC. | $37.88 | 2023-2024 | Entyvio |
| Qol Medical, LLC | $33.18 | 2023 | Sucraid |
| Davol INC. | $21.50 | 2025 | Phasix Mesh |
| Lilly USA, LLC | $18.53 | 2024 | Omvoh |
| Axsome Therapeutics, INC. | $17.70 | 2025 | Auvelity |
| Gilead Sciences, INC. | $16.59 | 2024 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Scientific Affairs, LLC | $14.91 | 2023 | Stelara |
| Pharmacosmos Therapeutics INC. | $14.68 | 2024 | Monoferric |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephanie Terrell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.